WebApr 11, 2024 · SAN CLEMENTE, Calif., April 11, 2024 (GLOBE NEWSWIRE) — ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 16/792,094, … WebJan 20, 2024 · Obalon Therapeutics and ReShape Lifesciences both focus on weight loss products. OBLN’s leading product is a weight loss balloon . This comes in the form of …
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc.
WebApr 11, 2024 · SAN CLEMENTE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences ... The patent will cover additional claims for the Obalon® Balloon System … WebApr 11, 2024 · ReShape Lifesciences has received a notice of allowance from the U.S. patent office for a patent application related to its Obalon balloon system.; The patent will cover additional claims for the Obalon balloon system and last until at least January 2031. It "significantly strengthens our intellectual property portfolio around innovations for the … new host on cheaters
2024-04-11 NDAQ:RSLS Press Release ReShape Lifesciences …
WebJan 20, 2024 · ReShape, Obalon, their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies from ReShape's and … WebOct 14, 2024 · Adverse effects. As summarized in Table 1, the characteristics, safety and efficacy of the Obera, ReShape, and Obalon IGBs are the precipitating factors for their … WebThe Orbera balloon has proven wonderful results. It is safe and effective, and it has a 100 percent placement success rate. In trials, patients lost three times more weight with the … new host on forged in fire